Iam graduated with bachelore degree from college of pharmacy university of Baghdad iat 2005 , complete master degree in clinical chemistry from college of pharmacy university of Baghdad at 2013 under the supervision of professor doctor Mohamed A. Taher, my thesisi name was ( Biochemical parameter study in iraqis patients with acromegaly), in 2020 complteat my PhD study in clinical chemistry from college of pharmacy university of Baghdad under the supervision of ass. prof. Dr. Eman Saadi , the name of the thesis was Fetuin A, resisitin and interleukin(13,19,38) levels in the serum of patients with multiple myeloma . now i work in college of pharmacy university of Baghdad as lecturrer Doctor in clinical laboratory sciences department
Bsc in pharmacy 2005 Msc in clinical chemistry 2013 PhD in clinical chemistry 2023
teaching under graduate
supervisor of graduation project students
member of numbers of commitees in collage of pharmacy/ Baghdad university
member of syndicate of Iraqis pharmacy
my research concern about the biochemical changes in that occur during several diseases , study different parameters in different diseases in order to determined if this parameters have the role in the diseases or can be considered as predictors or markers of these dideases
my academic area related to biochemical changes ibn the body and how the analytes change by the disaese
college of pharmacy/ university of Baghdad / 3rd stage biochemistry college of pharmacy/ university of Baghdad / 2nd stage microbiology college of pharmacy/ university of Baghdad / 5th stage lab training
supervise on the gradutaed project of the 5th years students the project i was supervise in 2023-2024: 1- elaf hikmet (level of il 2. 6 and 12 in the patients with multiple myeloma (2023-2024) 2. Ahmed murtadhta (the role adiponectin , resistin in type 2 DM)(2023-2024) 3. A li Salah (general study of Iraqis patients with DM)(2023-2024) 4. Marahob Rasheed ( the role of il 4. 10 and 13 in pathogenesity of inflammatory bowel disease )(2023-2024)
Multiple myeloma is hematological disease produces many complications in the bone, kidney, neural and other complications. The study aims to measure serum biomolecules like fetuin-A and resistin and determined the possibility to use these biomarkers as disease predictor. blood samples were isolated from 58 patients and 24 sex and age-matched control, serum then isolated, and proper ELISA kit then used to a determined level of B2 microglobulin, resistin, and fetuin-A. The result demonstrated significant increase in B2 microglobulin, fetuin-A and resistin in patients compare to control (1.3470.714 vs. 0.9130.253), p = 0.000, (14.00310.352 vs. 9.2594.264), p= 0.005, (1.9673.595 vs. 0.6040.622), p = 0.009, respectively. These di
... Show More
(2)
(1)
Acromegaly is a rare disease produce generalize and serious alteration in the patient with active disease. Many of these patients are also diabetic. Many analytes, hormones, markers are change in these disease. The objective of study is to assess the modification in a number of parameters that changed during the acromegaly as a result of excess in GH and IGF1 levels. The study included 36 patients and 38 healthy controls, paired by sex and age and BMI. Serum concentration of GH and the other parameters including (insulin, glucose, lipid profile, uric acid ) were determined by biochemical method .Compared to controls, acromegalic patients had increased levels of GH, insulin, glucose, triglyceride, very low density lipoprotein(VLDL) (p<0.05)
... Show More